In previous studies, we demonstrated the potential of both the tumor epithelium and the stroma for predicting the NAT response in patients with breast cancer; however, comprehensive image analysis and direct comparisons of TE and TS were not conducted. The gene discussed is BRD2; the disease is breast carcinoma.